|
CCDC77 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.40440000000208E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.160600E-03 |
| Normal-vs-Stage2 |
4.782100E-02 |
| Normal-vs-Stage3 |
4.990400E-02 |
| Normal-vs-Stage4 |
7.465400E-01 |
| Stage1-vs-Stage2 |
9.493800E-01 |
| Stage1-vs-Stage3 |
5.975800E-01 |
| Stage1-vs-Stage4 |
3.464400E-01 |
| Stage2-vs-Stage3 |
6.348000E-01 |
| Stage2-vs-Stage4 |
2.997000E-01 |
| Stage3-vs-Stage4 |
2.818000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.420790E-04 |
| Normal-vs-AfricanAmerican |
5.441200E-03 |
| Normal-vs-Asian |
6.836000E-02 |
| Caucasian-vs-AfricanAmerican |
6.608600E-01 |
| Caucasian-vs-Asian |
9.388000E-01 |
| AfricanAmerican-vs-Asian |
9.479000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.962100E-04 |
| Normal-vs-Female |
2.025600E-04 |
| Male-vs-Female |
2.290200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.307600E-02 |
| Normal-vs-Extreme_Weight |
4.839700E-02 |
| Normal-vs-Obese |
1.482570E-03 |
| Normal-vs-Extreme_Obese |
7.404200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.550200E-01 |
| Normal_Weight-vs-Obese |
5.803600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.970440E-01 |
| Extreme_Weight-vs-Obese |
3.036800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.531000E-01 |
| Obese-vs-Extreme_Obese |
5.068100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.098290E-03 |
| Normal-vs-Age(41-60Yrs) |
6.04909999999403E-05 |
| Normal-vs-Age(61-80Yrs) |
4.455200E-03 |
| Normal-vs-Age(81-100Yrs) |
4.794200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.683900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.931700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.721800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.440200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.573000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.09110000001689E-06 |
| Normal-VS-Type2 PRCC |
6.162200E-01 |
| Normal-VS-KIRP CIMP |
1.945840E-02 |
| Normal-VS-Unclassified PRCC |
2.193500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.578600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.084600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.087000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.010200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.435900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.523600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.828560E-01 |
| Normal-vs-N1 |
3.083900E-02 |
| Normal-vs-N2 |
5.949000E-01 |
| N0-vs-N1 |
1.057760E-01 |
| N0-vs-N2 |
7.133800E-01 |
| N1-vs-N2 |
8.435400E-01 |
|
|
